AbCellera Biologics Inc.
ABCLBiotechnology
$12.27−6.19%As of Oct 30vs prior close
- Market cap
- $4B
- P/E (TTM)
- –
- From 52W high
- −17.21%
- EPS (LTM)
- -$0.54
- Revenue (LTM)
- $66.2M
- Net margin
- -248.82%
- Dividend yield
- 0.00%
Nomior Score
50
Steady ProfileTop 50% of the scored universe
Growth34
Quality47
Value55
Momentum84
Resilience35
Growth
+36.51%revenue a year over 6 fiscal years
YE19 $11.6MLTM $66.2M
Connections
Revenue to profitQ2 YE26
The operating loss was 1550% of revenue, wider by 1260 pts on a year.